Lanean...

High Dose Erythropoietin in ELGANs does not Alter Risk of Retinopathy of Prematurity

INTRODUCTION: The Preterm Erythropoietin (Epo) Neuroprotection (PENUT) Trial sought to determine the safety and efficacy of early high-dose Epo as a potential neuroprotective treatment. We hypothesized that Epo would not increase the incidence or severity of retinopathy of prematurity (ROP). METHODS...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neonatology
Egile Nagusiak: Mayock, Dennis E., Xie, Zimeng, Comstock, Bryan A., Heagerty, Patrick J., Juul, Sandra E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7855231/
https://ncbi.nlm.nih.gov/pubmed/33113526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000511262
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!